Overview

Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
0
Participant gender:
All
Summary
Aggressive intraoperative and postoperative management of blood glucose may substantially decrease perioperative cardiovascular and infectious complications in diabetic and non-diabetic patients undergoing vascular surgery. The purpose of this study is to compare the tight versus traditional blood glucose control in diabetics and non-diabetics undergoing vascular surgery in regard to their postoperative fatal and nonfatal cardiac outcomes, and the secondary effects such as rate of infections, overall morbidity and 30-day mortality.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Abdominal aortic surgery

- Supra and infrainguinal peripheral vascular bypass surgery

- Below knee amputations

- Above knee amputations

- Diabetics and nondiabetics

- American Society of Anesthesiologists (ASA) I-III

Exclusion Criteria:

- Brittle diabetics

- ASA 1V,V

- Second surgery in same admission